Skip to main
ADUS

Addus HomeCare (ADUS) Stock Forecast & Price Target

Addus HomeCare (ADUS) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 14%
Buy 43%
Hold 29%
Sell 14%
Strong Sell 0%

Bulls say

Addus HomeCare is well-positioned to continue its growth trajectory through acquisitions and potential federal policy changes. The recent six-month Medicare moratorium is not expected to have a significant impact on the company's strategy. Potential upticks in M&A activity and the implementation of the company's new caregiver app should further improve its operational efficiency and drive revenue growth. Additionally, the recent integration of Helping Hands and potential future acquisition opportunities demonstrate the company's strong financial position and its ability to execute on large-scale deals. Furthermore, the company may face risks related to potential funding reforms in Medicaid and labor constraints, but its strong fundamentals and solid quarterly performance suggest a positive outlook for ADUS.

Bears say

Addus HomeCare is a provider of home-based, personal care services with a presence in hospice and home health segments. While their Hospice segment has shown healthy organic growth, their Home Health segment has had declining revenue and visits. Their recent acquisition and agreement to acquire personal care operations in Indiana may help increase revenue, but their balance sheet is still heavily leveraged, making future acquisitions uncertain.

Addus HomeCare (ADUS) has been analyzed by 7 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 43% recommend Buy, 29% suggest Holding, 14% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Addus HomeCare (ADUS) Forecast

Analysts have given Addus HomeCare (ADUS) a Buy based on their latest research and market trends.

According to 7 analysts, Addus HomeCare (ADUS) has a Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $127.43, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $127.43, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Addus HomeCare (ADUS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.